VireturnRevenue
6.1B USDAnnual · FY 2025EW
Edwards Lifesciences Corp
Operating income
1.3B USDAnnual · FY 2025Net income
1.1B USDAnnual · FY 2025Total assets
13.7B USDAnnual · FY 2025Equity
10.3B USDAnnual · FY 2025Operating cash flow
1.6B USDAnnual · FY 2025EW · Chart
Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.
Reported financial information
Revenue
USD
6.1B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 5.2B USD |
| FY 2022 | 4.5B USD |
| FY 2023 | 5B USD |
| FY 2024 | 5.4B USD |
| FY 2025 | 6.1B USD |
Operating income
USD
1.3B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 1.7B USD |
| FY 2022 | 1.5B USD |
| FY 2023 | 1.3B USD |
| FY 2024 | 1.4B USD |
| FY 2025 | 1.3B USD |
Net income
USD
1.1B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 1.5B USD |
| FY 2022 | 1.5B USD |
| FY 2023 | 1.4B USD |
| FY 2024 | 4.2B USD |
| FY 2025 | 1.1B USD |
Total assets
USD
13.7B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 8.5B USD |
| FY 2022 | 8.3B USD |
| FY 2023 | 9.4B USD |
| FY 2024 | 13.1B USD |
| FY 2025 | 13.7B USD |
Equity
USD
10.3B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 5.8B USD |
| FY 2022 | 5.8B USD |
| FY 2023 | 6.7B USD |
| FY 2024 | 10B USD |
| FY 2025 | 10.3B USD |
Operating cash flow
USD
1.6B USD
Period data
| Period | Value |
|---|---|
| FY 2021 | 1.7B USD |
| FY 2022 | 1.2B USD |
| FY 2023 | 895.8M USD |
| FY 2024 | 542.3M USD |
| FY 2025 | 1.6B USD |
Revenue growth
%
11.5%
Period data
| Period | Value |
|---|---|
| FY 2021 | 19.3% |
| FY 2022 | -14.7% |
| FY 2023 | 12.2% |
| FY 2024 | 8.6% |
| FY 2025 | 11.5% |
Operating income growth
%
-8.3%
Period data
| Period | Value |
|---|---|
| FY 2021 | 88.3% |
| FY 2022 | -11.4% |
| FY 2023 | -12.6% |
| FY 2024 | 5.3% |
| FY 2025 | -8.3% |
Net income growth
%
-74.3%
Period data
| Period | Value |
|---|---|
| FY 2021 | N/A |
| FY 2022 | 1.3% |
| FY 2023 | -7.9% |
| FY 2024 | 197.7% |
| FY 2025 | -74.3% |
Operating margin
%
20.8%
Period data
| Period | Value |
|---|---|
| FY 2021 | 32.3% |
| FY 2022 | 33.6% |
| FY 2023 | 26.1% |
| FY 2024 | 25.3% |
| FY 2025 | 20.8% |
Net margin
%
17.7%
Period data
| Period | Value |
|---|---|
| FY 2021 | 28.7% |
| FY 2022 | 34.1% |
| FY 2023 | 28% |
| FY 2024 | 76.7% |
| FY 2025 | 17.7% |
Return on assets
%
8%
Period data
| Period | Value |
|---|---|
| FY 2021 | 19.1% |
| FY 2022 | 18.1% |
| FY 2023 | 15.9% |
| FY 2024 | 37.2% |
| FY 2025 | 8% |
Debt/Equity
x
0.32x
Period data
| Period | Value |
|---|---|
| FY 2021 | 0.46x |
| FY 2022 | 0.43x |
| FY 2023 | 0.39x |
| FY 2024 | 0.3x |
| FY 2025 | 0.32x |